Join the Influenza group to help and get support from people like you.
Influenza News (Page 4)
Related terms: The Flu, Flu
Flu Vaccine Uptake Varies by Sociodemographic Factors in CKD Patients
TUESDAY, Sept. 26, 2023 – Among patients with chronic kidney disease (CKD), younger adults, Black individuals, and those with adverse social determinants of health are less likely to receive a flu...
Today's COVID Is Increasingly Looking Like a Cold or Flu
THURSDAY, Sept. 21, 2023 – Symptoms of mild COVID-19 infection have shifted this season, and now are more akin to those of allergies and the common cold, doctors say. Many people with COVID-19 now...
It's Time to Start Preparing Against Flu, RSV & COVID-19
FRIDAY, Sept. 15, 2023 – Kids are back in school and it’s time to think about viruses, for both yourself and them. It could be an early flu season in the United States, if what happened in the Sou...
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
THURSDAY, Sept. 14, 2023 – The immune response and occurrence of adverse events were similar for health care workers receiving coadministration of COVID-19 and influenza vaccines or COVID-19 vaccine...
Flu Vaccine Cut Risk for Influenza-Linked Hospitalizations in 2023
MONDAY, Sept. 11, 2023 – Influenza vaccination reduced the risk for influenza-associated hospitalizations by 52 percent in the March to September Southern Hemisphere 2023 influenza season, according...
In Good News for U.S., Flu Vaccine Working Well in South America
MONDAY, Sept. 11, 2023 – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South A...
Recommendations Updated for Flu Vaccine in Children
TUESDAY, Aug. 29, 2023 – Recommendations have been updated for influenza vaccination among U.S. children for the 2023 to 2024 season, according to a policy statement and accompanying technical...
Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
MONDAY, Aug. 21, 2023 – For patients with COVID-19, the incidence of new-onset persistent hypertension is higher than among those with influenza, according to a study published online Aug. 21 in...
When Cities Get a Pro Sports Team, Flu Deaths Rise
TUESDAY, Aug. 8, 2023 – Bringing a professional sports team to a new city often includes a big taxpayer-funded stadium subsidy, but new research shows that has a health downside: a spike in flu...
'Swine Flu' Strain Has Passed Between Humans & Pigs Hundreds of Times
FRIDAY, July 28, 2023 – It’s well known that some viruses make the leap from animals to humans, but a new study shows the influenza strain responsible for the 2009 H1N1 pandemic has been p...
How Common Are Co-Infections With COVID, Flu, RSV?
TUESDAY, July 25, 2023 – Results from more than 26,000 respiratory tests in late 2022 found simultaneous infections with COVID-19, influenza or respiratory syncytial virus (RSV) in more than 1% of...
Genentech Announces FDA Approval of Xofluza to Treat Influenza in Children Aged Five and Older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved for children as young as five years of age The FDA also approved Xofluza to prevent influenza in...
BioCryst Announces FDA Approval of Supplemental New Drug Application for Rapivab Expanding Patient Population to Include Children Six Months and Older
RESEARCH TRIANGLE PARK, N.C., Feb. 03, 2021 (GLOBE NEWSWIRE) – BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the U.S. Food and Drug Administration (FDA) has approved a...
Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person
South San Francisco, CA – November 23, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a...
Genentech Announces FDA Approval of Xofluza (baloxavir marboxil) for People at High Risk of Developing Influenza-Related Complications
South San Francisco, CA – October 17, 2019 – Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug...
Ask a question
To post your own question to this support group, sign in or create an account.